A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on markers of their metabolism in normal mucosa of colorectal adenoma patients

Cancer Research

Volumn 71, Issue 2, 2011, Pages 413-423

  Ahearn, Thomas U ^a,b   McCullough, Marjorie L ^a,c   Flanders, W Dana ^b,d   Long, Qi ^b,d   Sidelnikov, Eduard ^d   Fedirko, Veronika ^b,d   Daniel, Carrie R ^a,b   Rutherford, Robin E ^e   Shaukat, Aasma ^f   Bostick, Roberd M ^b,d  

^a Nutrition and Health Sciences Program   (United States)

^b EMORY UNIVERSITY   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

^d EMORY UNIVERSITY   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM SENSING RECEPTOR; COLECALCIFEROL; CYTOCHROME P450; PLACEBO; VITAMIN D RECEPTOR;

ADULT; ARTICLE; COLORECTAL ADENOMA; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; RANDOMIZED CONTROLLED TRIAL; RECTUM BIOPSY; RECTUM MUCOSA;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ADENOMA; CALCIUM; CHOLECALCIFEROL; COLORECTAL NEOPLASMS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PILOT PROJECTS; PRECANCEROUS CONDITIONS; RECEPTORS, CALCITRIOL; RECEPTORS, CALCIUM-SENSING; STEROID HYDROXYLASES; TUMOR MARKERS, BIOLOGICAL; VITAMIN D;

EID: 78751551316     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-1560     Document Type: Article

References (49)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer Statistics 2009. CA A Cancer Journal for Clinicians 2009;59:225-49.
2. Potter JD. Colorectal cancer: molecules and populations. J Natl Cancer Inst 1999;91:916-32.
3. Peterlik M, Grant WB, Cross HS. Calcium, vitamin D and cancer. Anticancer Res 2009;29:3687-98.
4. Kallay E, Bonner E, Wrba F, Thakker RV, Peterlik M, Cross HS. Molecular and functional characterization of the extracellular calcium- sensing receptor in human colon cancer cells. Oncol Res 2003;13:551-9.
5. Kallay E, Bises G, Bajna E, Bieglmayer C, Gerdenitsch W,Steffan I, et al. Colon-specific regulation of vitamin D hydroxylases-a possible approach for tumor prevention. Carcinogenesis 2005;26:1581-9.
6. McCullough ML, Giovannucci EL. Diet and cancer prevention. Oncogene 2004;23:6349-64.
7. Jiménez-Lara AM. Colorectal cancer: potential therapeutic benefits of Vitamin D. The Int J Biochem Cell Biol 2007;39:672-7.
8. Fedirko V, Bostick RM, Flanders WD, Long Q, Sidelnikov E, Shaukat A, et al. Effects of vitamin D and calcium on proliferation and differentiation in normal colon mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2009;18:2933-41.
9. Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, et al. Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. J Cell Biol 2001;154:369-88.
10. Bostick RM, Goodman M, Sidelnikov E. Genetics of Colorectal Cancer. New York: Springer Science + Business Media, LLC; 2009.
11. Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML, Church TR, et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 2003;95:1765-71.
12. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 2007;32:210-6.
13. Fedirko V, Bostick RM, Goodman M, Flanders WD, Gross MD. Blood 25-hydroxyvitamin D3 concentrations and incident sporadic colorectal adenoma risk: a pooled case-control study. Am J Epidemiol 2010;172:489-500.
14. Whitfield JF. The calcium-sensing receptor-a driver of colon cell differentiation. Curr Pharm Biotechnol 2009;10:311-6.
15. Cross HS, Kallay E. Regulation of the colonic vitamin D system for prevention of tumor progression: an update. Future Oncol 2009;5:493-507.
16. Cross HS, Bareis P, Hofer H, Bischof MG, Bajna E, Kriwanek S, et al. 25-Hydroxyvitamin D3-1α-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 2001;66:287-92.
17. Cross HS, Bises G, Lechner D, Manhardt T, Kállay E. The Vitamin D endocrine system of the gut-Its possible role in colorectal cancer prevention. J Steroid Biochem Mol Biol 2005;97:121-8.
18. Bises G, Kallay E, Weiland T, Wrba F, Wenzl E, Bonner E, et al. 25- Hydroxyvitamin D3-1α-hydroxylase expression in normal and malignant human colon. J Histochem Cytochem 2004;52:985-9.
19. Cross HS, Nittke T, Peterlik M. Modulation of vitamin D synthesis and catabolism in colorectal mucosa: a new target for cancer prevention. Anticancer Res 2009;29:3705-12.
20. Fedirko V, Bostick RM, Flanders WD, Long Q, Shaukat A, Rutherford RE, et al. Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, Placebo-controlled clinical trial. Cancer Prev Res 2009;2:213-23.
21. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, et al. Reproducibility and validity of a semiquantitative fodd frequency questionnaire. Am J Epidemiol 1985;122:51-65.
22. Bostick RM, Fosdick L, Lillemoe TJ, Overn P, Wood JR, Grambsch P, et al. Methodological findings and considerations in measuring colorectal epithelial cell proliferation in humans. Cancer Epidemiol Biomarkers Prev 1997;6:931-42.
23. Hollis BW. Quantitation of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers. Methods Enzymol 1997;282:174-86.
24. Hollis BW, Kamerud JQ, Kurkowski A, Beaulieu J, Napoli JL. Quantification of circulating 1,25-dihydroxyvitamin D by radioimmunoassay with 125I-labeled tracer. Clin Chem 1996;42:586-92.
25. Tangrea J, Helzlsouer K, Pietinen P, Taylor P, Hollis B, Virtamo J, et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 1997;8:615-25.
26. Wu K, Willett WC, Fuchs CS, Colditz GA, Giovannucci EL. Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst 2002;94:437-46.
27. Whitfield JF. Calcium, calcium-sensing receptor and colon cancer. Cancer Lett 2009;275:9-16.
28. 2+ in colon carcinomain colon carcinoma is dependent on calcium-sensing receptor expression and function. Int J Cancer 2007;121:1455-62.
29. Chakrabarty S, Radjendirane V, Appelman H, Varani J. Extracellular calcium and calcium sensing receptor function in human colon carcinomas: promotion of E-cadherin expression and suppression of β-Catenin/TCF activation. Cancer Res 2003;63:67-71.
30. Chakrabarty S, Wang H, Canaff L, Hendy GN, Appelman H, Varani J. Calcium sensing receptor in human colon carcinoma: interaction with Ca2+ and 1,25-dihydroxyvitamin D3. Cancer Res 2005;65:493-8.
31. Sheinin Y, Kallay E, Wrba F, Kriwanek S, Peterlik M, Cross HS. Immunocytochemical localization of the extracellular calcium-sensing receptor in normal and malignant human large intestinal mucosa. J Histochem Cytochem 2000;48:595-602.
32. Kallay E, Bajna E, Wrba F, Kriwanek S, Peterlik M, Cross HS. Dietary calcium and growth modulation of human colon cancer cells: role of the extracellular calcium-sensing receptor. Cancer Detect Prev 2000;24:127-36.
33. Cheng SX, Okuda M, Hall AE, Geibel JP, Hebert SC. Expression of calcium-sensing receptor in rat colonic epithelium: evidence for modulation of fluid secretion. Am J Physiol Gastrointest Liver Physiol 2002;283:G240-50.
34. Brenner BM, Russell N, Albrecht S, Davies RJ. The effect of dietary vitamin D3 on the intracellular calcium gradient in mammalian colonic crypts. Cancer Letters 1998;127:43-53.
35. Kállay E, Kifor O, Chattopadhyay N, Brown EM, Bischof MG, Peterlik M, et al. Calcium-dependent c-myc proto-oncogene expression and proliferation of CACO-2 cells: a role for a luminal extracellular calciumsensing receptor. Biochem Biophys Res Commun 1997;232:80-3.
36. Bhagavathula N, Kelley EA, Reddy M, Nerusu KC, Leonard C, Fay K, et al. Upregulation of calcium-sensing receptor and mitogen-activated protein kinase signalling in the regulation of growth and differentiation in colon carcinoma. Br J Cancer 2005;93:1364-71.
37. Canaff L, Hendy GN. Human calcium-sensing receptor gene. J Biol Chem 2002;277:30337-50.
38. Pence BC, Buddingh F. Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. Carcinogenesis 1988;9:187-90.
39. Oh K, Willett WC, Wu K, Fuchs CS, Giovannucci EL. Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women. Am J Epidemiol 2007;165:1178-86.
40. Zheng W, Anderson KE, Kushi LH, Sellers TA, Greenstein J, Hong CP, et al. A prospective cohort study of intake of calcium, vitamin D, and other micronutrients in relation to incidence of rectal cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev 1998;7:221-5.
41. Bareis P, Bises G, Bischof MG, Cross HS, Peterlik M. 25-hydroxyvitamin D metabolism in human colon cancer cells during tumor progression. Biochem Biophys Res Commun 2001;285:1012-7.
42. Lechner D, Kállay E, Cross HS. 1α,25-Dihydroxyvitamin D3 downregulates CYP27B1 and induces CYP24A1 in colon cells. Mol Cellular Endocrinol 2007;263:55-64.
43. Cross HS, Peterlik M, Reddy GS, Schuster I. Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: Expression of 25-hydroxyvitamin D3-1α-hydroxylase activity and regulation of sidechain metabolism. J Steroid Biochem Mol Biol 1997;62:21-8.
44. Bareis P, Kállay E, Bischof MG, Bises G, Hofer H, Pötzi C, et al. Clonal differences in expression of 25-hydroxyvitamin D3-1α- hydroxylase, of 25-hydroxyvitamin D3-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1α,25-dihydroxyvitamin D3. Exp Cell Res 2002;276:320-7.
45. Murillo G, Matusiak D, Benya RV, Mehta RG. Chemopreventive efficacy of 25-hydroxyvitamin D3 in colon cancer. J Steroid Biochem Mol Biol 2007;103:763-7.
46. Nittke T, Selig S, Kallay E, Cross HS. Nutritional calcium modulates colonic expression of vitamin D receptor and pregnane X receptor target genes. Mol Nutr Food Res 2008;52: S45-51.
47. Nittke T, Kallay E, Manhardt T, Cross HS. Parallel elevation of colonic 1,25-dihydroxyvitamin D3 levels and apoptosis in female mice on a calcium-deficient diet. Anticancer Res 2009;29:3727-32.
48. Fedirko V, Bostick RM, Long Q, Flanders WD, McCullough ML, Sidelnikov E, et al. Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2010;19:280-91.
49. Liu G, Hu X, Chakrabarty S. Vitamin D mediates its action in human colon carcinoma cells in a calcium-sensing receptor-dependent manner: Downregulates malignant cell behavior and the expression of thymidylate synthase and survivin and promotes cellular sensitivity to 5-FU. Int J Cancer 2010;126:631-9.